For citations:
Markova T.N., Lysenko M.A., Stas M.S., Anchutina A.A. Efficacy and safety of glucagon-like peptide-1 receptor agonists therapy initiation in patients with type 2 diabetes hospitalized with coronavirus infection. Diabetes mellitus. 2023;26(6):537-548. (In Russ.) https://doi.org/10.14341/DM13015
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
